The Drug Delivery to the Lungs Conference (DDL) is in it’s 36th year and attracts in excess of 1100 attendees worldwide, including scientists, academics, clinicians, regulators and industry experts. The conference includes a large industry exhibition, supported by 117 international companies, a scientific poster hall, expert lectures and excellent networking opportunities over the 3-day event. DDL actively supports young scientists by offering free registration for students, Career Development Grants and a variety of awards, recognising their achievements.

DDL offers the opportunity for 

• lectures
• posters
• networking
• and exhibitions 

to be closely located thereby enhancing interactions and networking opportunities for attendees, presenters and exhibitors.

DDL is a not-for-profit conference and any surplus funds are provided as grants or awards, targeting research and training of the next generation of aerosol and drug delivery scientists. 

Registration Link